Iridex Corp (IRIX) Misses Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Reddit leads social media platforms in revenue growth per user
- L3Harris CEO steps down amid conduct review, shares drop
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
- US considers new sanctions on Brazilian judge, FT reports
- Six dead in 'stampede-like' incident at India temple, ANI says
Iridex Reports First Quarter 2023 Financial Results
May 11, 2023 4:05 PM EDTMOUNTAIN VIEW, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today reported financial results for the first quarter ended April 1, 2023.
First Quarter 2023 Highlights
Generated total revenue of $13.7 million, an increase of 2% year-over-yearCyclo G6® product family revenue of $3.7 million increased 4% year-over-year 61 Cyclo G6 Glaucoma Laser Systems sold, compared to 56 in the prior year periodCyclo G6 probe revenue increased 6% year-over-year on decreased unit sales of 13,800 probes... More